Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome
NCT00452192
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Metabolic Syndrome
Interventions
DRUG:
Telmisartan
Sponsor
University of Erlangen-Nürnberg Medical School